4153 Share Price Performance
NT$37.90
-6.50 (-14.64%)
Price NT$37.90
Share PriceNT$37.90
DIVA Laboratories, Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
4153 Community Narratives
There are no narratives available yet.
Recent 4153 News & Updates
DIVA Laboratories, Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 1.52
- Gross Margin
- 31.02%
- Net Profit Margin
- 10.35%
- Debt/Equity Ratio
- 0%
DIVA Laboratories, Ltd. Competitors
Snowflake Analysis
About 4153
- Founded
- 1995
- Employees
- n/a
- CEO
- WebsiteView website
DIVA Laboratories, Ltd. engages in the development, manufacture, and sale of medical equipment and computer related devices worldwide. The company provides endo/surgical displays, a static and dynamic image for hybrid and integrated ORs, and control room applications; color and mono displays for radiology and medical imaging applications; touch displays/human machine interface products; medical and industrial cases; and displays to original design manufacturers (ODM) and original equipment manufacturers (OEMs) customers. It also offers video solutions. DIVA Laboratories, Ltd. was incorporated in 1995 and is headquartered in New Taipei City, Taiwan.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Taiwanese Market Performance
- 7 Days: 1.9%
- 3 Months: 19.3%
- 1 Year: 17.3%
- Year to Date: 18.3%
Over the last 7 days, the market has risen 1.9%, driven by gains of 2.2% in the Information Technology sector. As for the past 12 months, the market is up 17%. As for the next few years, earnings are expected to grow by 18% per annum. Market details ›